Apollo Hospitals Enterprise (APOLLOHOSP) Weekly Analysis
Price & Volume
The stock saw a slight decrease of 0.21% this week, closing at 8822.5. The trading range was 1.73%, indicating moderate price movement. Average daily trading volume was higher than the previous week by 10.89%. The stock's closing price is 4.38% above its 50-day moving average and 12.91% above its 200-day moving average.
Technicals
This week, the stock closed at 8822.5, a slight decrease of 0.21% WoW. The price remains above its 50-week Moving Average (MA), which is trending upwards. Momentum shows mixed signals: the RSI is at 59.95, down WoW, indicating cooling momentum, while the MACD histogram has turned negative, suggesting a bearish shift. Bollinger Band width is 6.84%, indicating moderate volatility.
Fundamentals
In the Mar 2026 quarter, Apollo Hospitals Enterprise reported a 18.1% YoY revenue increase and a 33.1% YoY net profit growth. The operating margin stood at 15.0% for the quarter. The company currently trades at a Price-to-Earnings (PE) ratio of 84.5x and a Price-to-Book (PB) ratio of 12.7x, reflecting its market valuation.
News
During the week of July 13, 2026, Apollo Hospitals Enterprise experienced significant market attention. On July 13, a wealth management research desk recommended buying the stock. Subsequently, the company's stock hit new 52-week highs multiple times throughout the week, with reports indicating rallies of up to 20-25% over the preceding month. Despite reaching record highs, including ₹8,948.10 on the BSE, some reports noted a marginal decline by the end of the period. Analysts expressed optimism about continued upside and strong momentum for Apollo Hospitals.
Events
Apollo Hospitals Enterprise Limited announced its Board of Directors will meet on August 12, 2026, to approve Q1 FY27 standalone and consolidated financial results. The trading window will remain closed until August 14, 2026.
Apollo Hospitals Enterprise Limited has submitted a certificate confirming dematerialization of securities for the quarter ended June 30, 2026, as per SEBI regulations. This assures shareholders about the proper handling of their shares.
Shareholders, secured creditors, and unsecured creditors of Apollo Hospitals Enterprise Limited have approved a composite scheme of arrangement. This approval is a key step in the proposed amalgamation of Apollo Hospitals Enterprise Limited with Apollo Healthco Limited, Keimed Private Limited, and Apollo Healthtech Limited.
Apollo Hospitals Enterprise Limited announced that shareholders, secured creditors, and unsecured creditors have approved the composite scheme of arrangement with Apollo Healthco Limited, Keimed Private Limited, and Apollo Healthtech Limited. This signifies progress in the company's restructuring efforts.
Apollo Hospitals Enterprise Limited announced the closure of its trading window from July 1, 2026, until 48 hours after the declaration of Q1 FY27 financial results, in compliance with SEBI regulations.
ICRA has assigned a credit rating to a company, indicating its financial health and creditworthiness. This rating is crucial for investors to assess the risk associated with the company's debt instruments.
Apollo Hospitals Enterprise Limited has submitted a certificate confirming dematerialization of securities for the quarter ended June 30, 2026, as per SEBI regulations. This assures shareholders about the proper handling of their shares.
Shareholders, secured creditors, and unsecured creditors of Apollo Hospitals Enterprise Limited have approved a composite scheme of arrangement. This approval is a key step in the proposed amalgamation of Apollo Hospitals Enterprise Limited with Apollo Healthco Limited, Keimed Private Limited, and Apollo Healthtech Limited.
Apollo Hospitals Enterprise Limited announced that shareholders, secured creditors, and unsecured creditors have approved the composite scheme of arrangement with Apollo Healthco Limited, Keimed Private Limited, and Apollo Healthtech Limited. This signifies progress in the company's restructuring efforts.
Apollo Hospitals Enterprise Limited announced the closure of its trading window from July 1, 2026, until 48 hours after the declaration of Q1 FY27 financial results, in compliance with SEBI regulations.
ICRA has assigned a credit rating to a company, indicating its financial health and creditworthiness. This rating is crucial for investors to assess the risk associated with the company's debt instruments.
Weekly Snapshot
Highlights
- The stock experienced a slight decline of 0.21% this week, closing at 8822.5, despite positive long-term indicators.
- Trading volume increased by 10.89% week-over-week, indicating higher investor interest.
- The stock's price remains above its 50-day and 200-day moving averages, suggesting a positive long-term trend.
- Momentum indicators show mixed signals, with RSI cooling and MACD exhibiting a bearish cross.
- Apollo Hospitals Enterprise reported strong Q1 FY27 results with 18.1% YoY revenue and 33.1% YoY net profit growth.
What This Means
Despite a slight price dip this week, Apollo Hospitals Enterprise maintains a positive long-term outlook, evidenced by its stock trading above key moving averages. Increased trading volume suggests growing investor interest. However, mixed momentum indicators, with a bearish MACD cross and cooling RSI, warrant attention. Recent strong quarterly results provide a fundamental tailwind, but the market's reaction to these indicators will be crucial.
Latest Quarter Info
The company demonstrated robust revenue growth in the Mar 2026 quarter, with an 18.13% year-over-year increase, signaling strong market traction. Quarter-over-quarter revenue growth was more modest at 1.99%. Profitability trends show a positive trajectory, with net profit increasing by 33.09% year-over-year, outpacing revenue growth. However, the quarter-over-quarter net profit growth was 6.78%. The operating margin remained stable at 15.0%, indicating consistent operational efficiency. The mix of signals suggests sustained long-term momentum, supported by healthy year-over-year improvements in key financial metrics, while quarter-over-quarter figures show a more moderate pace of expansion.